Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01752907 · ClinicalTrials.gov registry record · Phase 2
Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
A Phase 2 study, sponsored by Amgen.
- Completed
- Registry status
- Phase 2
- Development phase
- 304
- Enrollment target
NCT01752907 is a Phase 2 study that has completed, run by Amgen. The registered enrollment target is 304 participants.
The verdict
NCT01752907, a Phase 2 study, has completed, sponsored by Amgen.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 304 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if patient education can affect patient reported bone pain in breast cancer patients receiving chemotherapy and pegfilgrastim.
Interventions
- OTHER General Education DVD
- OTHER Bone Pain Education DVD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 304 participants |
| Start Date | 2013-01-17 |
| Est. Completion | 2014-12-15 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01752907
The ClinicalTrials.gov registry entry for NCT01752907 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 304 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Amgen, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which General Education DVD is the first listed.
NCT01752907 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01752907 about?
NCT01752907 is a clinical study titled "Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim". The purpose of this study is to determine if patient education can affect patient reported bone pain in breast cancer patients receiving chemotherapy and pegfilgrastim.
What is the current status of trial NCT01752907?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 304 participants. The study started on 2013-01-17. Estimated completion is 2014-12-15.
What interventions are being tested in trial NCT01752907?
The interventions under investigation include: General Education DVD (OTHER), Bone Pain Education DVD (OTHER).
Who is sponsoring clinical trial NCT01752907?
This trial is sponsored by Amgen, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.